Highlights

  • Praemium reported AUD 34.353 bn in platform funds under administration at September-end.
  • Wrkr doubled its active organisation count and reported an estimated AUD 17 mn annual Recurring Revenue run rate.
  • Pharmx recorded higher quarterly revenue and continued expanding pharmacy ordering and supplier integrations.
  • Platform scale, customer adoption and transaction activity are distinct measures of progress for these financial workflows.

Behind the familiar language of digital transformation sit three distinct infrastructure businesses. Praemium Limited (ASX:PPS) supports advisers administering Investment assets, Wrkr Ltd (ASX:WRK) connects employers to Superannuation processes, and Pharmx Technologies Limited (ASX:PHX) operates pharmacy ordering networks. The companies traded at AUD 0.598, AUD 0.080 and AUD 0.069, respectively, on 13 November 2026.

Investment Assets Give the Platform Scale

Praemium reported platform funds under administration of AUD 34.353 bn at 30 September 2026, up 7.4% year-on-year. During the quarter, inflows of AUD 1.784 bn exceeded outflows of AUD 1.510 bn, producing AUD 274 mn in net platform flows. The figures show both the scale of assets being serviced and the direction of client movements. Funds under administration are not the company’s revenue, however; fee structures and asset composition determine how platform scale becomes earnings. Praemium shares rose 4.83% to AUD 0.598 on 13 November. Its adviser-facing technology and reporting services remain at the centre of the operating model, while investment-market movements and adviser Demand are relevant variables to monitor.

Employer Connections Translate Into Usage

Wrkr reported 67,000 active organisations at September-end, more than double the 31,800 recorded in June. Registered tax file numbers increased to 2.43 mn, while contributing numbers reached 1.23 mn. Its estimated annual recurring revenue stood at AUD 17 mn, up 27% from June, and cash was AUD 14.6 mn. These metrics point to platform onboarding and usage, but a revenue run rate is not the same as audited sales over twelve months. On 13 November the stock gained 1.27% to AUD 0.080. The next practical measure is whether employer activation and transaction participation remain durable as the customer base expands.

Pharmacy Networks Expand Digitally

Pharmx reported a 9% year-on-year increase in September-quarter revenue in its October update. The Marketplace platform reached AUD 6.9 mn of September gross transaction value, while Gateway orders rose 12% and associated gross transaction value increased 15%. Its Relay electronic-data-interchange solution also went live at Sigma Healthcare’s South Auckland distribution centre with 12 supplier integrations completed. The company traded unchanged at AUD 0.069 on 13 November. Gross transaction value measures activity passing through a network rather than revenue earned by Pharmx. Future results will depend on how successfully that activity turns into platform income and how effectively new integrations operate at scale.

Network Activity Is Not the Same as Earnings

Comparisons between the three operators require particular care. Praemium’s AUD 34.353 bn figure measures client assets on its platform, not the amount it books as fees. Wrkr’s AUD 17 mn run rate estimates annualised recurring income at a point in time, while its registered-number statistics describe how widely a system is being adopted. Pharmx’s Marketplace gross transaction value measures Business passing through the platform, not net retained revenue. Those differences matter when interpreting apparent scale. The market prices also represent different levels of trading liquidity. A platform can be adding users and transactions while still needing disciplined implementation, pricing and customer support to produce durable financial outcomes.

What Comes Next?

Together, the stocks show why financial and commercial platforms cannot be compared using one metric alone. Assets administered, registered users and transaction value all describe different stages of business activity; their conversion into sustainable revenue remains the central question.